Afon Technology says that its Glucowear non-invasive continuous glucose monitor (CGM) demonstrated significant accuracy in its first trial.

Insulet (Nasdaq:PODD) today initiated a voluntary medical device correction for specific lots of Omnipod 5 insulin pump pods.

MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO).

Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its Mobi automated insulin delivery system available with ...

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.

An Illinois judge sided with Abbott (NYSE:ABT) in a lawsuit related to alleged data sharing with its continuous glucose ...

Roche today announced findings from a global survey highlighting the logistical and emotional challenges faced by people with ...

Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence.